{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:29:36Z","timestamp":1790422176167,"version":"4.1.0"},"reference-count":87,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,2,17]],"date-time":"2005-02-17T00:00:00Z","timestamp":1108598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> A growing body of evidence indicates that human immunodeficiency virus (HIV)\u2010positive individuals are more likely to be infected with hepatitis B virus (HBV) than HIV\u2010negative individuals, possibly as a result of shared risk factors. There is also evidence that HIV\u2010positive individuals who are subsequently infected with HBV are more likely to become HBV chronic carriers, have a high HBV replication rate, and remain hepatitis Be antigen positive for a much longer period. In addition, it is evident that immunosuppression brought about by HIV infection may cause reactivation or reinfection in those previously exposed to HBV. Furthermore, HIV infection exacerbates liver disease in HBV co\u2010infected individuals, and there is an even greater risk of liver disease when HIV and HBV co\u2010infected patients are treated with highly active anti\u2010retroviral therapy (HAART). Complicating matters further, there have been several reports linking HIV infection to \u2018sero\u2010silent\u2019 HBV infections, which presents serious problems for diagnosis, prevention, and control. In sub\u2010Saharan Africa, where both HIV and HBV are endemic, little is known about the burden of co\u2010infection and the interaction between these two viruses. This paper reviews studies that have investigated HIV and HBV co\u2010infection in sub\u2010Saharan Africa, against a backdrop of what is currently known about the interactions between these two viruses.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2005.01054.x","type":"journal-article","created":{"date-parts":[[2005,3,17]],"date-time":"2005-03-17T10:31:08Z","timestamp":1111055468000},"page":"201-213","source":"Crossref","is-referenced-by-count":108,"title":["Hepatitis B virus and human immunodeficiency virus co\u2010infection in sub\u2010Saharan Africa: a call for further investigation"],"prefix":"10.1111","volume":"25","author":[{"given":"R. J.","family":"Burnett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Kew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Leroux\u2010Roels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Meheus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Hoosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Mphahlele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,3,17]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"161","volume-title":"Viral Hepatitis and Liver Disease","author":"Ayoola E A.","year":"1988"},{"issue":"2","key":"e_1_2_8_3_2","first-page":"S31","article-title":"Progress towards the comprehensive control of hepatitis B in Africa","volume":"38","author":"Kew M C.","year":"1996","journal-title":"a view from South Africa"},{"issue":"2","key":"e_1_2_8_4_2","first-page":"S5","article-title":"The epidemiology and prophylaxis of hepatitis B in sub\u2010Saharan Africa","volume":"38","author":"Kiire C F.","year":"1996","journal-title":"a view from tropical and subtropical Africa"},{"issue":"1","key":"e_1_2_8_5_2","first-page":"12","article-title":"Epidemiology and control of hepatitis B","volume":"17","author":"Mphahlele M J","year":"2002","journal-title":"implications for eastern and southern Africa"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92876-6"},{"key":"e_1_2_8_7_2","first-page":"198","volume-title":"Viral Hepatitis and Liver Disease","author":"Taylor P E","year":"1988"},{"issue":"3","key":"e_1_2_8_8_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00271876","article-title":"Modification of the immune response against hepatitis B virus by the human immunodeficiency virus","volume":"9","author":"Hess G","year":"1989","journal-title":"Rheumatol Int"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1089\/10872910050206577"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.323"},{"issue":"10","key":"e_1_2_8_11_2","first-page":"837","article-title":"Hepatitis B in patients with HIV infection","volume":"117","author":"Scharschmidt B F","year":"1992","journal-title":"relationship to AIDS and patient survival"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.3.339"},{"key":"e_1_2_8_13_2","unstructured":"UNAIDS.AIDS Epidemic Update December 2001.http:\/\/www.unaids.org\/epidemic_update\/report_dec01\/index.html"},{"key":"e_1_2_8_14_2","unstructured":"UNAIDS.AIDS Epidemic Update December 2002.http:\/\/www.unaids.org\/html\/pub\/Publications\/IRC\u2010pub03\/epiupdate2002_en_pdf.pdf"},{"key":"e_1_2_8_15_2","unstructured":"CDC Website 2004:http:\/\/www.cdc.gov\/ncidod\/diseases\/hepatitis\/slideset\/hep_b\/slide_9.htm"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2613.2001.iep178.x"},{"issue":"3","key":"e_1_2_8_17_2","first-page":"362","article-title":"Hepatitis B","volume":"61","author":"Maddrey W C.","year":"2000","journal-title":"an important public health issue"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199906)58:2<111::AID-JMV2>3.0.CO;2-B"},{"key":"e_1_2_8_19_2","first-page":"523","volume-title":"Basic Pathology","author":"Lipscomb M F.","year":"1992"},{"key":"e_1_2_8_20_2","first-page":"137","volume-title":"Viral Hepatitis. Scientific Basis and Clinical Management","author":"Buendia M A","year":"1993"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50453"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.5.1138"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.3.454"},{"issue":"2","key":"e_1_2_8_24_2","first-page":"111","article-title":"Coinfection and superinfection of hepatitis B virus in patients infected with human immunodeficiency virus","volume":"29","author":"Sinicco A","year":"1997","journal-title":"no evidence of faster progression to AIDS"},{"key":"e_1_2_8_25_2","first-page":"S11","article-title":"Hepatitis B","volume":"16","author":"Grob P J.","year":"1998","journal-title":"virus, pathogenesis and treatment"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00456-9"},{"key":"e_1_2_8_27_2","first-page":"1","article-title":"Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi","volume":"65","author":"Candotti D","year":"2001","journal-title":"high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses"},{"issue":"4","key":"e_1_2_8_28_2","first-page":"213","article-title":"Prevalence of transmissible blood infections among blood donors at the University of Maiduguri Teaching Hospital, Maiduguri, Nigeria","volume":"74","author":"Chikwem J O","year":"1997","journal-title":"East Afr Med J"},{"issue":"3","key":"e_1_2_8_29_2","first-page":"167","article-title":"Prevalence of transfusion\u2010associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania","volume":"76","author":"Matee M I N","year":"1999","journal-title":"East Afr Med J"},{"issue":"3","key":"e_1_2_8_30_2","first-page":"628","article-title":"Hepatitis B virus activation among Central Africans infected with human immunodeficiency virus (HIV) type I","volume":"169","author":"Kashala O","year":"1994","journal-title":"pre-s2 antigen is predominantly expressed in HIV infection"},{"issue":"10","key":"e_1_2_8_31_2","first-page":"789","article-title":"Unsafe injections in the developing world and transmission of bloodborne pathogens","volume":"77","author":"Simonsen L","year":"1999","journal-title":"a review"},{"issue":"9297","key":"e_1_2_8_32_2","first-page":"1989","article-title":"The injection century","volume":"358","author":"Drucker E","year":"2001","journal-title":"massive unsterile injections and the emergence of human pathogens"},{"key":"e_1_2_8_33_2","unstructured":"Safe Injection Global Network (Sign) Website April 2004:http:\/\/www.injectionsafety.org"},{"key":"e_1_2_8_34_2","unstructured":"Global Alliance for Vaccines and Immunisation (GAVI) website April 2004:http:\/\/www.vaccinealliance.org\/reference\/awards.html"},{"issue":"9","key":"e_1_2_8_35_2","first-page":"1026","article-title":"Infant and adolescent hepatitis B immunisation up to 1999","volume":"19","author":"Vryheid R E","year":"2000","journal-title":"a global overview"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)93137-P"},{"issue":"4","key":"e_1_2_8_37_2","first-page":"277","article-title":"Universal immunization of infants with low doses of a low\u2010cost, plasma\u2010derived hepatitis B vaccine in South Africa","volume":"80","author":"Schoub B D","year":"2002","journal-title":"Bull World Health Organ"},{"issue":"28","key":"e_1_2_8_38_2","first-page":"3919","article-title":"The first five years of universal hepatitis B vaccination in South Africa","volume":"19","author":"Tsebe K V","year":"2001","journal-title":"evidence for elimination of HBsAg carriage in under 5-year-olds"},{"issue":"2","key":"e_1_2_8_39_2","first-page":"103","article-title":"Should pregnant urban South African women be screened for hepatitis B?","volume":"83","author":"Guidozzi F","year":"1993","journal-title":"S Afr Med J"},{"issue":"11","key":"e_1_2_8_40_2","first-page":"1","article-title":"US Public Health Service. Updated. US Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis","volume":"50","year":"2001","journal-title":"MMMR"},{"issue":"8675","key":"e_1_2_8_41_2","first-page":"1330","article-title":"Hepatitis B","volume":"2","author":"Gilson R J C","year":"1989","journal-title":"reactivation or reinfection associated with HIV-1 infection"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91347-0"},{"issue":"3","key":"e_1_2_8_43_2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1096-9071(199907)58:3<215::AID-JMV5>3.0.CO;2-K","article-title":"Prevalence and mother\u2010to\u2010infant transmission of hepatitis viruses B, C, and E in Southern Tanzania","volume":"58","author":"Menendez C","year":"1999","journal-title":"J Med Virol"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890460318"},{"issue":"5","key":"e_1_2_8_45_2","first-page":"355","article-title":"The prevalence of hepatitis B surface antigen (HBsAg), anti\u2010hepatitis B surface (anti\u2010HBs) and anti\u2010hepatitis B core (anti\u2010HBc) in patients with acquired immuno\u2010deficiency syndrome (AIDS)","volume":"67","author":"Ogutu E O","year":"1990","journal-title":"East Afr Med J"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(98)91983-1"},{"key":"e_1_2_8_47_2","unstructured":"BurnettR J Fran\u00e7oisG HoosenA A Leroux\u2010RoelsG MeheusA MphahleleM J.Three\u2010year analysis of HBV infection in HIV\u2010infected antenatal women from national HIV surveys in South Africa. Proceedings of the 11th International Symposium on Viral Hepatitis and Liver Disease Sydney Australia April 2003 (Abstract WC4\u201001)."},{"issue":"1","key":"e_1_2_8_48_2","first-page":"13","article-title":"Hepatitis B and C virus infections and liver function in AIDS patients at Chris Hani Baragwanath Hospital, Johannesburg","volume":"77","author":"Lodenyo H","year":"2000","journal-title":"East Afr Med J"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01997062"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/47.5.303"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00156822"},{"issue":"2","key":"e_1_2_8_52_2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4314\/eamj.v79i2.8903","article-title":"Hepatitis B virus and HIV infections among patients in Mulago hospital","volume":"79","author":"Nakwagala F N","year":"2002","journal-title":"East Afr Med J"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(01)90015-X"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200209010-00012"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(96)90227-8"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(99)90010-X"},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(90)90412-8"},{"key":"e_1_2_8_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890370302"},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92906-X"},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150404"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800001497"},{"key":"e_1_2_8_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11913-1"},{"issue":"1","key":"e_1_2_8_63_2","first-page":"182","article-title":"Hepatotoxicity associated with nevirapine or efavirenz\u2010 containing antiretroviral therapy","volume":"35","author":"Sulkowski M S","year":"2002","journal-title":"Role of hepatitis C and B infections"},{"key":"e_1_2_8_64_2","doi-asserted-by":"publisher","DOI":"10.1086\/317535"},{"key":"e_1_2_8_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199206000-00008"},{"issue":"4","key":"e_1_2_8_66_2","first-page":"450","article-title":"Serological pattern \u201canti\u2010HBc alone\u201d","volume":"62","author":"Grob P","year":"2000","journal-title":"report on a workshop"},{"key":"e_1_2_8_67_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2002.00344.x"},{"issue":"8","key":"e_1_2_8_68_2","first-page":"613","article-title":"Detection of HBV DNA from serologically negative or \u201csilent\u201d HBV infections \u2013 viral or host factors?","volume":"92","author":"Mphahlele M J","year":"2002","journal-title":"S Afr Med J"},{"key":"e_1_2_8_69_2","first-page":"441","article-title":"Hepatitis B virus DNA in serum of healthy black African adults positive for hepatitis B surface antibody alone","volume":"64","author":"Owiredu W K B A","year":"2001","journal-title":"Possible association with recombination between genotypes A and D"},{"key":"e_1_2_8_70_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01584356"},{"key":"e_1_2_8_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00019-3"},{"key":"e_1_2_8_72_2","unstructured":"XiangJ GeorgeS L KlinzmanD StapletonJ T.HBV viraemia in HIV\u2010positive individuals. Proceedings of the 10th International Symposium on Viral Hepatitis and Liver Disease 9\u201313 April 2000 Atlanta GA USA (Abstract B033)."},{"key":"e_1_2_8_73_2","unstructured":"MphahleleM J MoropengM L NgobeniM J BurnettR J.Detection and quantification of HBV DNA in HBsAg negative patients co\u2010infected with HIV. Proceedings of the 11th International Symposium on Viral Hepatitis and Liver Disease Sydney Australia April 2003 (Abstract WF1)."},{"key":"e_1_2_8_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00431-2"},{"key":"e_1_2_8_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00416-1"},{"issue":"12","key":"e_1_2_8_76_2","first-page":"90","article-title":"Expanded programme on immunization (EPI). Immunization schedules in the WHO African region, 1996","volume":"71","author":"World Health Organization.","year":"1996","journal-title":"Wkly Epidemiol Rec"},{"issue":"7","key":"e_1_2_8_77_2","first-page":"973","article-title":"The predicted pattern of emergence of vaccine\u2010resistant hepatitis B","volume":"17","author":"Wilson J N","year":"1999","journal-title":"a cause for concern?"},{"key":"e_1_2_8_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02132-2"},{"key":"e_1_2_8_79_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.302.6772.313"},{"key":"e_1_2_8_80_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.1998.0050s2025.x"},{"key":"e_1_2_8_81_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300309"},{"key":"e_1_2_8_82_2","first-page":"3799","article-title":"Mutant hepatitis B viruses","volume":"19","author":"Fran\u00e7ois G","year":"2001","journal-title":"a matter of academic interest only or a problem with far-reaching implications?"},{"issue":"9203","key":"e_1_2_8_83_2","first-page":"561","article-title":"Consensus statement","volume":"355","author":"European Consensus Group on Hepatitis B Immunity.","year":"2000","journal-title":"Are booster immunisations needed for lifelong hepatitis B immunity?"},{"key":"e_1_2_8_84_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890330105"},{"key":"e_1_2_8_85_2","first-page":"103","article-title":"Clinical and immunological aspects of hepatitis B virus infection in children receiving multidrug cancer chemotherapy","volume":"8","author":"Repp R","year":"1993","journal-title":"Arch Virol"},{"key":"e_1_2_8_86_2","first-page":"61","article-title":"Immunisation of children at risk of infection with human immunodeficiency virus","volume":"81","author":"Moss W J","year":"2003","journal-title":"Bull World Health Organ"},{"key":"e_1_2_8_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00389-8"},{"key":"e_1_2_8_88_2","first-page":"97","article-title":"Immunological responses to low\u2010dose plasma derived hepatitis B vaccine in infants of mothers infected with the human immune deficiency virus (HIV)","volume":"18","author":"Gray G","year":"2000","journal-title":"J. Clin Virol"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2005.01054.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2005.01054.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T13:23:00Z","timestamp":1697116980000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2005.01054.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,17]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1111\/j.1478-3231.2005.01054.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2005.01054.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,17]]}}}